BioSpark Competition

BioSpark is a competitive live pitch event for life sciences start-ups that takes place during the annual BioDiscovery Summit and is co-hosted by CvilleBioHub and Cooley. The event will be held Thursday, September 17, 2026 at 9:00 am at the Irving Theater, 225 W. Water Street in Charlottesville.

Applications for BioSpark will open on June 1st, 2026.

BioSpark Pitch Eligibility

  • Pre-seed or seed-stage company with formal entity
  • Entity has full ownership rights to technology
  • No more than $10M raised to date
  • Open to U.S.-based companies
  • One entry per company

BioSpark Pitch Categories

The submitted product or service must fall under one of the following categories:

  • Therapeutics
  • Digital Health and Analytics
  • Medical Devices
  • Diagnostics
  • Healthcare Delivery
  • AI Healthcare Service
  • Healthcare Adjacent Technologies

BioSpark Pitch Process

  • After the application process, eight companies will be invited to deliver an in-person pitch before a panel of judges and an audience of life sciences investors and summit attendees
  • Pitches will consist of 8-minute presentations plus 5 minutes of Q&A with the panel of judges
  • A pitch deck of no more than 15 slides must include: the problem, solution, value/science, business model, progress, data, fundraising ask, use of funds, team, and competitive landscape
  • Selected companies are required to participate in an in-person runthrough on September 16th
  • Selected companies are expected to stay for the awards presentation on the afternoon of September 17 during the BioDiscovery Summit program

BioSpark Pitch Prizes

Participating companies are eligible for $30,000 in cash prizes. One company will receive a year of access to CBH’s Commonwealth BioAccelerator.

BioSpark Judging Criteria

Customer and Problem – 20%
Who is the product/solution targeted to and why?
Solution and Benefits – 20%
Does the product successfully address the stated problem?
Innovation – 20%
What makes the solution unique, better, or different?
Ability to Execute – 20%
Is the team experienced, capable, and possessing the expertise needed to execute?
Effective Presentation – 20%

2025 BioSpark Recap